The effects of the pandemic were felt by Stemmer Imaging in the 2020 fiscal year, as revenue in most of the firm's key markets and industries declined.
The company posted revenue of €105.2m in 2020, compared to €120.6m in the previous year.
However, following a tough second quarter of 2020, business showed a steady increase in key performance indicators, with order intake growing 14 per cent in the second half of the year compared to the first half.
Overall, order intake for the year was €113.9m, down on the previous year's amount of €119.4m. Group EBITDA was €7.2m (€10.8m in the previous year).
Stemmer Imaging continued to expand in the artificial vision segment last year and increased its share of total revenues to almost 40 per cent (previous year 37 per cent). Increasing the share of revenue in the end-customer business was advanced through focused sales activities and by expanding the range of value-added services, the company stated.
Arne Dehn, CEO of Stemmer Imaging, commented: 'The positive development in order intake, turnover and earnings in the second half of 2020 shows that we were right to decisively focus on our growth topics at an early stage. We are particularly pleased that we were able to further advance our strategic goals with the expansion of the share of non-industrial customers in the area of artificial vision and the business with end customers.
'The trend of the second half of 2020, continued at the beginning of the current year, allows us to look positively to 2021 and beyond,' he added.
Stemmer Imaging expects growth in the mid-single-digit range up to 15 per cent for 2021, with sales predicted at between €111m and €121m.
